Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 501.40B | 472.65B | 439.02B | 441.22B | 442.07B |
Gross Profit | 196.57B | 187.12B | 175.72B | 176.01B | 175.78B |
EBITDA | 40.69B | 39.07B | 36.19B | 39.52B | 42.72B |
Net Income | 14.21B | 14.05B | 13.23B | 15.59B | 18.65B |
Balance Sheet | |||||
Total Assets | 479.01B | 458.56B | 419.25B | 398.08B | 395.10B |
Cash, Cash Equivalents and Short-Term Investments | 10.84B | 11.72B | 9.22B | 12.24B | 14.68B |
Total Debt | 193.19B | 184.10B | 158.80B | 147.38B | 147.06B |
Total Liabilities | 313.21B | 301.30B | 269.70B | 255.63B | 261.81B |
Stockholders Equity | 165.79B | 157.26B | 149.55B | 142.44B | 133.28B |
Cash Flow | |||||
Free Cash Flow | 2.23B | 3.74B | -6.22B | 6.35B | 20.31B |
Operating Cash Flow | 22.44B | 22.49B | 9.40B | 17.44B | 35.12B |
Investing Cash Flow | -21.72B | -24.01B | -17.93B | -12.68B | -15.22B |
Financing Cash Flow | -1.43B | 2.50B | 5.43B | -7.29B | -17.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥188.80B | 11.10 | 3.06% | 6.96% | -19.43% | ||
78 Outperform | ¥122.82B | 13.77 | 2.83% | 2.78% | 15.97% | ||
71 Outperform | ¥155.43B | 10.55 | 1.75% | 1.84% | -3.32% | ||
67 Neutral | ¥261.79B | 13.64 | 6.45% | 2.57% | 5.11% | -13.15% | |
67 Neutral | ¥120.19B | 7.94 | 2.63% | 4.89% | 7.47% | ||
62 Neutral | ¥31.51B | 14.84 | 1.52% | 3.11% | -5.40% | ||
57 Neutral | €52.58B | 265.97 | 0.09% | 3.11% | -5.51% | -96.59% |